RD - Commission on Dietetic Registration (CDR) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Enhance your career with the RD - Commission on Dietetic Registration (CDR) test. Prepare using flashcards and multiple choice questions. Get ready for success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which decision-making process is most suitable for determining the best approach to lower serum triglyceride levels?

  1. Decision tree

  2. Cost-effectiveness analysis

  3. Network chart

  4. Cost-benefit analysis

The correct answer is: Cost-effectiveness analysis

The cost-effectiveness analysis is a suitable decision-making process for determining the best approach to lower serum triglyceride levels because it allows for a comparison of the relative costs and outcomes of different interventions aimed at this health issue. In the context of healthcare and public health, cost-effectiveness analysis helps identify which strategies provide the best outcomes for the resources invested. When considering various approaches to manage or lower triglyceride levels, it’s essential to not only look at the costs associated with each intervention but also to evaluate their effectiveness in achieving the desired health outcomes, such as reducing triglyceride levels or decreasing related cardiovascular risks. By using cost-effectiveness analysis, practitioners can weigh the benefits of different treatments or lifestyle modifications against their costs, enabling a more informed and economically sound decision-making process. This method can help prioritize interventions that deliver the greatest health benefit relative to their cost, ultimately improving patient care and resource allocation. In contrast, decision trees and network charts are more suited for mapping out decisions and potential outcomes rather than directly comparing costs and effectiveness. Cost-benefit analysis, while useful, may not focus specifically on the health outcomes of lowering triglyceride levels, making cost-effectiveness analysis more appropriate in this specific scenario.